No Barrier, a San Francisco, CA–based AI-powered medical interpretation platform, has raised $2.7 million in Seed funding.
Investors
The round was led by A Squared Ventures and Esplanade Ventures, with additional participation from Rock Health and Fusion.
A Squared Ventures supports and funds early-stage entrepreneurs harnessing software to address unmet business needs in healthcare. The firm invests in B2B and B2B2C healthcare IT, tech-enabled services, and pharma-tech companies operating in the U.S. market.
Esplanade Ventures is a Canadian venture capital firm investing in digital health and AI-enabled software companies aiming to transform healthcare in North America and globally. The firm specializes in Seed to Series A funding rounds, seeking bold ideas that improve access, efficiency, and outcomes.
No Barrier Use of Funds
The funding will be used to accelerate expansion across all communication points, from check-in to diagnosis and treatment planning.
About No Barrier
No Barrier is a HIPAA- and SOC 2–compliant, AI-driven platform for medical interpretation. It is designed to bridge language and cultural gaps between healthcare providers and patients with limited English proficiency (LEP). No Barrier integrates directly into clinical workflows to provide real-time medical interpretation across more than 40 languages with zero wait time. Headquartered in San Francisco, California, No Barrier’s mission is to remove language barriers in healthcare. The platform is already deployed across more than 100 sites in 12 states.
Funding Details
Company: No Barrier, Inc.
Raised: $2.7M
Round: Seed
Funding Date: November 2025
Lead Investors: A Squared Ventures, Esplanade Ventures
Additional Investors: Rock Health, Fusion
Company Website: https://www.nobarrier.ai/
Software Category: Healthcare AI / Medical Interpretation
Source: https://www.nobarrier.ai/post/no-barrier-ai-interpretation-healthcare-funding